Rodolphe joined FdC in December 2022. He is a French ‘Ingenieur’ in Chemistry and has a MSc in finance from the Lyon School of Management. He worked about 10 years as an equity research analyst covering healthcare at Bryan Garnier, Kepler Chevreux and Societe Générale. He then became head of the ECM/M&A activity on the biotech/medtech sector at Societe Générale, where he has made about 60 deals (IPOs, fund raising for listed/non-listed companies, mergers, divestments…). Rodolphe then developed and managed eureKARE, an investment company in the biotech field, for which he rasied 50M€ with international family offices. He is at the inititative, co-founder and sponsor of eureKING, the first healthcare SPAC in France dedicated to biomanufacturing, which raised 150M€ on Euronext in May 2022.